- ICH GCP
- Registro de ensayos clínicos de EE. UU.
- Ensayo clínico NCT07614711
The Effect of Cancer Awareness Web-Based Education in Schools
The Effect of Web-Based Cancer Awareness Education in Schools on Students' Knowledge Level, Help-Seeking Behaviors, and Stigma Attitudes
Objective: This study aims to determine the effect of web-based cancer awareness education in schools on students' knowledge levels, help-seeking attitudes, and stigma attitudes.
Method: The Web-Based Adolescent Cancer Education (WAKE) study was planned as a school-based, randomized controlled experimental study. Qualified high schools in the public sector of Izmir province will constitute the study population. Private schools are excluded for adolescents whose additional needs cannot be met in inclusive education. Two schools will be selected using a purposive sampling method (15-18 age group) and assigned to the experimental and control groups. This will prevent interaction between students in both schools. Students in each school will be listed, and assignments to groups will be made using a web-based randomizer application with randomly selected numbers (https://www.randomizer.org/). Data will be collected using the Cancer Awareness Scale (CAM), the Cancer Stigma Scale (CASS-T), and a Basic Demographic Questionnaire. In the evaluation of the data, descriptive statistics (number, percentage, and statistic) will be used, and repeated measures analysis of variance will be employed to assess the effect of the intervention. Differences in results between the experimental and control groups will be tested using multiple regression methods.
Descripción general del estudio
Estado
Intervención / Tratamiento
Tipo de estudio
Inscripción (Estimado)
Fase
- No aplica
Contactos y Ubicaciones
Ubicaciones de estudio
-
-
-
Izmir, Turquía (Türkiye), 35130
- Dokuz Eylül University Hospital
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
- Niño
- Adulto
Acepta Voluntarios Saludables
Descripción
Inclusion Criteria:
- Being a student aged 15-18 in selected schools
- Volunteers who have withdrawn must agree to participate
- Parents must fill out an informed consent form
- Lack of literacy skills
Exclusion Criteria:
- Having a problem that will prevent communication
- Students who do not agree to the study
- Students whose parents' permission cannot be obtained
- Not being able to access and use the internet
- The student wants to voluntarily withdraw from the research
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Prevención
- Asignación: Aleatorizado
- Modelo Intervencionista: Asignación paralela
- Enmascaramiento: Ninguno (etiqueta abierta)
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Experimental: Web-Based Cancer Awareness Education
Students receive a web-based cancer awareness education program delivered in school settings, providing education on cancer awareness, help-seeking behaviors, and cancer-related stigma.
|
A web-based educational program delivered in school settings that provides education on cancer-related knowledge, help-seeking behaviors, and cancer-related stigma.
|
|
Sin intervención: No Cancer Awareness Education Control
Students do not receive the web-based cancer awareness education program during the study period.
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Cancer Awareness Level
Periodo de tiempo: Baseline (pre-intervention), immediately after the intervention, 1 month after the intervention, and 3 months after the intervention.
|
Cancer Awareness Level: Cancer awareness will be assessed using the Cancer Awareness Measure (CAM).
The CAM measures multiple dimensions of cancer awareness, including awareness of cancer warning signs, cancer risk factors, and help-seeking behavior.
Total scores range from 0 to 77, with higher scores indicating greater cancer awareness.
|
Baseline (pre-intervention), immediately after the intervention, 1 month after the intervention, and 3 months after the intervention.
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Cancer-Related Stigma Attitudes
Periodo de tiempo: Baseline (pre-intervention), immediately after the intervention, 1 month after the intervention, and 3 months after the intervention.
|
Cancer-related stigma attitudes will be assessed using the Cancer Stigma Scale-Turkish (CASS-T).
The scale measures attitudes toward individuals with cancer and cancer-related stigma.
Total scores range from 25 to 150, with higher scores indicating greater perceived stigma.
|
Baseline (pre-intervention), immediately after the intervention, 1 month after the intervention, and 3 months after the intervention.
|
Colaboradores e Investigadores
Patrocinador
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Actual)
Finalización primaria (Estimado)
Finalización del estudio (Estimado)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Actual)
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Palabras clave
Otros números de identificación del estudio
- Institute of Health Sciences
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .